Enzo Biochem (ENZ) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	67.21M
Short term investments
Accounts receivable, net of allowances	14.06M
Inventories	7.25M
Prepaid expenses	1.92M
Total current assets	90.44M
Property, plant and equipment, net	8.28M
Goodwill	7.45M
Intangible assets, net	3.97M
Other	334K
Total assets	110.47M
Accounts payable – trade	9.34M
Accrued liabilities	8.51M
Other current liabilities	926K
Total current liabilities	20.78M
Deferred taxes
Other	1.2M
Commitments and contingencies	0
Preferred Stock, $.01 par value; authorized 25,000,000 shares; no shares issued or outstanding	0
Common Stock, $.01 par value; authorized 75,000,000 shares; shares issued: 39,141,353 at April 30, 2012 and 39,045,837 at July 31, 2011	463K
Additional paid-in capital	326.45M
Less treasury stock at cost: 216,556 shares at April 30, 2012 and 450,014 at July 31, 2011
Accumulated deficit	-240.87M
Accumulated other comprehensive income	2.45M
Total stockholders’ equity	88.49M
Total liabilities and stockholders’ equity	110.47M

Entities mentioned with ENZ

View All Entities